The 28 references in paper A. Burlutskaia V., V. Firsova N., А. Бурлуцкая В., В. Фирсова Н. (2017) “СИНДРОМ НЕПЕРЕНОСИМОСТИ ГИСТАМИНА У ДЕТЕЙ // SYNDROME OF CHILDREN S HISTAMINE INTOLERANCE” / spz:neicon:ksma:y:2017:i:4:p:185-190

1
Кампс А.Р. Клинические аспекты питания и непереносимости гистамина у детей с симптомами хронического нарушения пищеварения. – М.: 2015. 156 с.
(check this in PDF content)
2
Asher M.L. ISAAC Steering Committee. Clin. Exp. Allergy. 1998; 28(5): 52 -66.
(check this in PDF content)
3
Humbert M. Editorial 100* International Conference of the Amer. Thoracic Society. SCAN. 2004: 3.
(check this in PDF content)
4
Asher M.L. International Study of Asthma and Allergies in Childhood (ISAAC). Amer. Thoracic Society. S CAN. 2004: 3.
(check this in PDF content)
5
Передерий В.Г., Губская Е.Ю. Целиакия − самое частое заболевание тонкой кишки. – Киев, Вистка. 2013. 112 с.
(check this in PDF content)
6
Гацкая Д.А., Корицкая И.В. Динамика распространенности аллергических заболеваний среди детей и молодежи (результаты первого этапа эпидемиологического исследования). Астма и аллергия. 2015; 1: 17-22.
(check this in PDF content)
7
Dale H.D., Laidlaw P.D. The physiological action of β-iminazolylethylamine. J. Physiol (London). 1910 (41): 318-344.
(check this in PDF content)
8
Maintz L., Bieber T., Novak N. Histamine intolerance in clinical practice. DtschArttebl. 2006; 103 (51-52): 3477-3483.
(check this in PDF content)
9
Vlie-Boerstra B.J., Van der H. S., Oude Elberink J.N. et al. Mastocytosis and adverse reactionsto biogenic amines and histamine releasing foods: what is the evidence? Neth J. Med. 2005;63: 244-249.
(check this in PDF content)
10
Ring J. Angewandte Allergologie (Implemented allergology). J. Ring. – Munich, Germany: Urban & Vogel, 2004.
(check this in PDF content)
11
Maintz L., Novac N. Histamine and histamine intolerance. Clin. Nutr.2007; 85: 1185-1196.
(check this in PDF content)
12
Bieganski T. Biochemical, physiological and pathophysiological aspects of intestinal diamine oxidase. Acta Physiolo Pol. 1983; 34: 139-154.
(check this in PDF content)
13
Cataldi M., Borriello F., Granata F. et al. Histamine receptors and antihistamines: from Discovery to clinical applications. Chem. Imunol. Allergy. 2014; 100: 214-226.
(check this in PDF content)
14
Thurmond R.L. The histamine H4 receptors: from orphan to the clinic. Front Pharmacol. 2015; 31(6): 65.
(check this in PDF content)
15
Ellenbroek B.A., Ellenbroek B.A., Ghiabi B. The other side of the histamine H3 receptor. Trends Neurosci. 2014; 37(4): 191-195.
(check this in PDF content)
16
Tabarean I.V. Histamine receptor signaling in energy homeostasis. Neuropharmacology. 2015: 21.
(check this in PDF content)
17
Komericki P., Klein G., Reider N. et al. Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: a randomized, double-blind, placebo-controlled crossover study. Wien Klin Wochenschr. 2011; 123(1-2): 15-20. DOI: 10.1007/s00508-010-1506-y.
(check this in PDF content)
18
Zampeli E., Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. British Journal of Pharmacology. 2009; 157: 24-33.
(check this in PDF content)
19
Дейл М. М.,Формен Дж. К. Руководство по иммунофармакологии. − М.: Медицина; 1998, 332 с.
(check this in PDF content)
20
Colome Rivero G., Tormo Carnicer R., Rosell Camps A. et al. Diaminooxidase low levels and paediatric gastrointestinal pathology. 47Th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. 9-12 June 2014. Jerusalem, Israel.
(check this in PDF content)
21
Steinbrecher I. Histamin und Kopfschmerz. Allergologie. 2005; 28: 84-91.
(check this in PDF content)
22
Verma A., Deb D.K., Sassano A. et al. Cutting edge: activation of the p38 mitogen activated protein kinase signaling pathway mediates cytokineinducedhemopoietic suppression in aplastic anemia. J. Immunol. 2002; 168: 5984-5988.
(check this in PDF content)
23
Black A.K. Unusual urticarias. J. Dermatol. 2001; 28 (11): 632-634.
(check this in PDF content)
24
Arock M., Valent P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev. Hematol. 2010; 3: 497-516.
(check this in PDF content)
25
Jadid-Niaragh F., Mirshafiey A. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology. 2010; 59: 180-189.
(check this in PDF content)
26
Kofler H., Aberrer W., Deibi M. et al. Diamine oxidase (DAO) serum activity: not a useful marker for diagnosis of histamine intolerance. Allergologie. 2009; 32: 105-109.
(check this in PDF content)
27
Music E., Korosec P., Silar M. et al. Serum diamineoxidasa activity as a diagnostic test for histamine intolerance. Wien Kin Wochenschr. 2013; 125(9-10): 239-43.
(check this in PDF content)
28
Schwelberger H.G. Histamine intolerance: overestimated or underestimated. Inflamm Res. 2009; 58(1): 51-52.
(check this in PDF content)